Dauphin Technology

Dauphin Technology, Inc. was a publicly traded company that transitioned from the computer hardware industry into the healthcare and biotechnology sectors in the mid-2000s. This strategic shift was marked by the 2005 acquisition of Oncologix, Inc., a medical technology firm, leading to a corporate name change to Oncologix Tech, Inc. The company's core focus was the development and commercialization of the 'A-Cell' device, which utilized proprietary acoustical cellular technology for the non-invasive treatment of various cancers. Beyond its medical device pipeline, the company expanded into the healthcare services market through subsidiaries providing home health care and medical staffing. Despite its efforts to penetrate the oncology market, the company faced financial difficulties and regulatory challenges. The SEC eventually revoked the company's registration in 2015, and it is currently considered inactive.